SEHK:1948
SEHK:1948Media

Asian Penny Stocks To Watch In January 2026

As 2026 begins, Asian markets are capturing attention with their dynamic movements, particularly as investors navigate the broader global economic landscape. Penny stocks, though often seen as a niche investment area, continue to hold potential for those seeking value and growth in smaller or newer companies. Despite being an older term, penny stocks can still offer significant opportunities when backed by strong financial health; here we explore a few that stand out for their promising...
SEHK:823
SEHK:823Retail REITs

A Look At Link REIT (SEHK:823) Valuation After Extended Interim Leadership And CEO Search Update

Leadership changes and why they matter for Link Real Estate Investment Trust Link Real Estate Investment Trust (SEHK:823) is back in focus after Link Asset Management confirmed an extended interim leadership setup, following the former Group CEO’s departure at the end of 2025. Mr. John Russell Saunders, previously Group Chief Investment Officer, has been appointed Executive Director, working alongside Executive Director and Group Chief Financial Officer Mr. Ng Kok Siong under this temporary...
SEHK:6618
SEHK:6618Consumer Retailing

Why JD Health (SEHK:6618) Is Up 13.3% After Strong Quarterly Results And Analyst Endorsement

CICC recently maintained its Buy rating on JD Health International, Inc. and reiterated confidence in the company following a quarter of strong year-over-year revenue and profit growth. This combination of upbeat analyst commentary and improved financial performance has reinforced investor attention on JD Health’s position in China’s online healthcare market. Now, we’ll explore how this stronger quarterly performance may influence JD Health’s existing investment narrative built around...
SEHK:883
SEHK:883Oil and Gas

CNOOC (SEHK:883) Valuation Check As Buzios6 Production Starts In Brazil

CNOOC (SEHK:883) has reported first oil from the Buzios6 Project in Brazil’s pre salt Buzios field, a large deep water development that lifts the oilfield’s installed capacity to 1.15 million barrels per day. See our latest analysis for CNOOC. Despite the Buzios6 milestone and recent board changes in late December, CNOOC’s HK$20.94 share price sits after a mixed patch, with a 1 day share price return of 1.26% but a 7 day share price return decline of 4.21%, while the 90 day share price return...
SEHK:6855
SEHK:6855Biotechs

A Look At Ascentage Pharma Group International's Valuation After FDA IND Clearance For APG-3288

Ascentage Pharma Group International (SEHK:6855) has drawn fresh attention after announcing that its BTK-targeted protein degrader APG-3288 received U.S. FDA IND clearance, allowing a global Phase I trial in relapsed or refractory B-cell malignancies. See our latest analysis for Ascentage Pharma Group International. The FDA IND clearance for APG-3288 comes as Ascentage Pharma’s share price sits at HK$54.95, with a 1-day share price return of 1.20% and a 7-day share price return of 7.96%,...
SEHK:1177
SEHK:1177Pharmaceuticals

Assessing Sino Biopharmaceutical (SEHK:1177) Valuation After Fresh IPF And Psoriasis Trial Milestones

Sino Biopharmaceutical (SEHK:1177) has just reported two key clinical milestones, including first patient enrollment in a Phase III trial for IPF drug candidate TDI01 and positive Phase II data for psoriasis treatment TQH3906. See our latest analysis for Sino Biopharmaceutical. The latest clinical updates arrive after a mixed year for Sino Biopharmaceutical’s shares. The stock has a 7.39% year-to-date share price return at HK$6.83, a 12.44% decline over 90 days, and a very large 1-year total...